In exchange for a full release of claims, Dey has agreed to pay the state $4.75 million, of which $750,000 accounts for outside legal fees and expenses. As part of the settlement, the state acknowledges that the settlement does not constitute admission or evidence of fault, liability or unlawful conduct by Dey.
As part of the acquisition agreement between Mylan (Dey’s parent company) and Merck KGaA (Dey’s former parent company), Merck has agreed to indemnify Mylan in connection with this settlement and for all liability for all pending and future related Medicaid reimbursement lawsuits involving Dey.